Concord Biotech settles on debut day with 27% gains despite

Concord Biotech | The stock performance was much higher than analysts' expectations as well as grey market premium which was around 15 percent over the issue price.

Related Keywords

India , United States , Technoplast Ipo Clickhere , Quadria Capital Fund Helix Investment Holdings , Zaggle Prepaid Ocean Services , Drug Administration , Concord Biotech , United States Food , Rakesh Jhunjhunwala , Establishment Inspection Report , Latest Subscription Figures , Pyramid Technoplast , Quadria Capital Fund , Helix Investment Holdings , Concord Biotech Share Price , Concord Biotech Stock Price , Concord Biotech Nse Price , Concord Biotech Price On Bse , Concord Biotech Bse Price , Concord Biotech Price Today , Concord Biotech Share Price Today ,